GEN lists the top five performing biotech stocks of 2025 and the five biotech stocks that fell the most during this past year, with brief explanations for the increases or declines.

New findings could aid future development of more efficient therapeutic strategies in the context of regenerative medicine and aging.

JAX and the NYSCF celebrated the official launch of their unified organization with a ribbon-tying ceremony at NYSCF’s Manhattan research facilities.

AI can move beyond prediction to purposeful molecular design, creating proteins that meet clearly defined research and therapeutic goals.

Researchers suggest that MultiCell could potentially be used to discern early patterns of disease, such as in asthma.

Engineered dendritic cells capture tumor EVs, enhancing antigen presentation and T cell activation to boost cancer immunotherapy in preclinical models.

Vaccines that display filovirus surface proteins on engineered, self-assembling protein nanoparticles improve immune system detection of the virus.

A new brain-computer interface promises ultra-high resolution neural recording and wireless operation in a very small form.

Lyophilization model can help optimize freeze-drying steps for continuous manufacturing processes, according to MIT researchers.

Investigations suggest V2P may be efficiently applied for the automated identification of causal variants in simulated and actual patient sequencing data across phenotypes.

New data highlight liver-encoded delivery of immune modulators as a strategy to mitigate age-related immune dysfunction.

Chai Discovery has completed a $130 million Series B financing that the artificial intelligence (AI)-based antibody designer says will help it accelerate its research and product development, as well ...